Quarterly Results

  • Company Name :
Gland Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543245
  • NSE Symbol:
  • GLAND
  • P/E(TTM):
  • 22.00
  • ISIN Demat:
  • INE068V01023
  • Div & Yield%:
  • 1.34
  • EPS(TTM):
  • 68.05
  • Book Value(₹):
  • 556.80
  • Market Cap(₹Cr.):
  • 24,664.98
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars December 2024 ( Cr)September 2024 ( Cr)June 2024 ( Cr)
Gross Sales 1,010.78 1,062.99 1,012.02
Excise Duty 0.00 0.00 0.00
Net Sales 1,010.78 1,062.99 1,012.02
Other Operating Income 0.00 0.00 0.00
Other Income 65.06 57.80 48.49
Total Income 1,075.85 1,120.79 1,060.51
Total Expenditure 619.64 699.19 718.47
PBIDT 456.21 421.60 342.04
Interest 18.31 0.17 0.91
PBDT 437.90 421.43 341.13
Depreciation 43.77 41.62 40.82
Tax 95.09 96.33 76.21
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 3.92 1.77 1.18
Reported Profit After Tax 295.12 281.71 222.92
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 295.12 281.71 222.92
EPS (Unit Curr.) 17.91 17.10 13.53
EPS (Adj) (Unit Curr.) 17.91 17.10 13.53
Calculated EPS (Unit Curr.) 17.91 17.10 13.53
Calculated EPS (Adj) (Unit Curr.) 17.91 17.10 13.53
Calculated EPS (Ann.) (Unit Curr.) 71.65 68.40 54.12
Calculated EPS (Adj) (Ann.) (Unit Curr.) 71.65 68.40 54.12
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 16.48 16.48 16.48
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 45.13 39.66 33.80
PBDTM(%) 43.32 39.65 33.71
PATM(%) 29.20 26.50 22.03